About LL-37
LL-37 is the only human cathelicidin antimicrobial peptide and is widely used in immunology and innate-immunity research. Supplied as a lyophilized powder for laboratory investigations into innate immune signaling, host-defense pathway markers, and immunomodulatory mechanisms in controlled experimental models. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: >95-99 (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.
Recent research on LL-37: Device-Free Auricular Acupressure for Rosacea: A Randomized Clinical Trial.
Read Full Study on PubMedFull-length brain-derived α-synuclein fibril models reveal fuzzy-coat control of peptide recognition.
Recent research on LL-37: Full-length brain-derived α-synuclein fibril models reveal fuzzy-coat control of peptide recognition.
Read Full Study on PubMedAdditional Studies
RK-14: A Novel Antimicrobial Peptide Targeting Multidrug-Resistant Bacteria and Catheter-Associated Biofilms.
Recent research on LL-37: RK-14: A Novel Antimicrobial Peptide Targeting Multidrug-Resistant Bacteria and Catheter-Associated Biofilms.
Read on PubMedA portable N-terminal biphenyl motif in LL-37 enhances the activity of short human cathelicidin derivatives.
Recent research on LL-37: A portable N-terminal biphenyl motif in LL-37 enhances the activity of short human cathelicidin derivatives.
Read on PubMedLL-37-based oral antimicrobial therapeutics: translational challenges and future directions-a narrative review.
Recent research on LL-37: LL-37-based oral antimicrobial therapeutics: translational challenges and future directions-a narrative review.
Read on PubMedApoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling.
Recent research on LL-37: Apoptosis Modulation by LL-37: From Mitochondrial Cell Death to Prosurvival Signaling.
Read on PubMedCathelicidin LL-37 inhibits angiogenesis and migration in gastric cancer via inhibition of NF-κB/IL-6 signaling.
Recent research on LL-37: Cathelicidin LL-37 inhibits angiogenesis and migration in gastric cancer via inhibition of NF-κB/IL-6 signaling.
Read on PubMedRational hybrid design and computational characterization of PA-Hyb1: a novel peptide inhibitor targeting the MexB efflux pump in Pseudomonas aeruginosa.
Recent research on LL-37: Rational hybrid design and computational characterization of PA-Hyb1: a novel peptide inhibitor targeting the MexB efflux pump in Pseudomonas aeruginosa.
Read on PubMedRelated Research
Purchase LL-37 from Origin Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.